Rejuve.Bio Launches Groundbreaking Crowd Fund on NetCapital to Pioneer the Future of Artificial General Intelligence and Longevity

Embark on a journey to redefine aging with cutting-edge biotech innovation. LOS ANGELES, March 12, 2024 /PRNewswire/ — Rejuve.Bio, a leading AI biotechnology firm at the forefront of the longevity revolution, announces its latest initiative: a Crowd Fundraise on the NetCapital platform….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.